The lipid droplet-associated protein ABHD5 protects the heart through proteolysis of HDAC4.


Journal

Nature metabolism
ISSN: 2522-5812
Titre abrégé: Nat Metab
Pays: Germany
ID NLM: 101736592

Informations de publication

Date de publication:
11 2019
Historique:
entrez: 20 11 2019
pubmed: 20 11 2019
medline: 20 11 2019
Statut: ppublish

Résumé

Catecholamines stimulate the first step of lipolysis by PKA-dependent release of the lipid droplet-associated protein ABHD5 from perilipin to co-activate the lipase ATGL. Here, we unmask a yet unrecognized proteolytic and cardioprotective function of ABHD5. ABHD5 acts

Identifiants

pubmed: 31742248
doi: 10.1038/s42255-019-0138-4
pmc: PMC6861130
mid: EMS84593
pii: 10.1038/s42255-019-0138-4
doi:

Substances chimiques

Repressor Proteins 0
1-Acylglycerol-3-Phosphate O-Acyltransferase EC 2.3.1.51
ABHD5 protein, human EC 2.3.1.51
Serine Proteases EC 3.4.-
HDAC4 protein, human EC 3.5.1.98
Histone Deacetylases EC 3.5.1.98

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

1157-1167

Subventions

Organisme : Austrian Science Fund FWF
ID : F 7303
Pays : Austria
Organisme : Austrian Science Fund FWF
ID : P 24857
Pays : Austria

Déclaration de conflit d'intérêts

Competing Interests Statement Z.H.J., L.H.L, O.J.M, H.A.K. and J.B. filed a patent on HDAC4-NT and ABHD5 gene therapy (US9914912B2). All other authors declare no conflict of interest.

Références

Lohse, M. J., Engelhardt, S. & Eschenhagen, T. What is the role of beta-adrenergic signaling in heart failure? Circ. Res. 93, 896–906 (2003).
pubmed: 14615493 doi: 10.1161/01.RES.0000102042.83024.CA
Dewenter, M., von der Lieth, A., Katus, H. A. & Backs, J. Calcium signaling and transcriptional regulation in cardiomyocytes. Circ. Res. 121, 1000–1020 (2017).
pubmed: 28963192 doi: 10.1161/CIRCRESAHA.117.310355
Rockman, H. A., Koch, W. J. & Lefkowitz, R. J. Cardiac function in genetically engineered mice with altered adrenergic receptor signaling. Am. J. Physiol. 272, H1553–H1559 (1997).
pubmed: 9139936
Wang, H. et al. Unique regulation of adipose triglyceride lipase (ATGL) by perilipin 5, a lipid droplet-associated protein. J. Biol. Chem. 286, 15707–15715 (2011).
pubmed: 21393244 pmcid: 3091179 doi: 10.1074/jbc.M110.207779
Yamaguchi, T. et al. CGI-58 facilitates lipolysis on lipid droplets but is not involved in the vesiculation of lipid droplets caused by hormonal stimulation. J. Lipid Res. 48, 1078–1089 (2007).
pubmed: 17308334 doi: 10.1194/jlr.M600493-JLR200
Sahu-Osen, A. et al. CGI-58/ABHD5 is phosphorylated on Ser239 by protein kinase a: control of subcellular localization. J. Lipid Res. 56, 109–121 (2015).
pubmed: 25421061 pmcid: 4274058 doi: 10.1194/jlr.M055004
Haemmerle, G. et al. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-alpha and PGC-1. Nat. Med. 17, 1076–1085 (2011).
pubmed: 21857651 pmcid: 3244833 doi: 10.1038/nm.2439
Zierler, K. A. et al. Functional cardiac lipolysis in mice critically depends on comparative gene identification-58. J. Biol. Chem. 288, 9892–9904 (2013).
pubmed: 23413028 pmcid: 3617289 doi: 10.1074/jbc.M112.420620
Pollak, N. M. et al. The interplay of protein kinase A and perilipin 5 regulates cardiac lipolysis. J. Biol. Chem. 290, 1295–1306 (2015).
pubmed: 25418045 doi: 10.1074/jbc.M114.604744
Lass, A. et al. Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in chanarin-dorfman syndrome. Cell Metab. 3, 309–319 (2006).
pubmed: 16679289 doi: 10.1016/j.cmet.2006.03.005
Cerk, I. K., Wechselberger, L. & Oberer, M. Adipose triglyceride lipase regulation: an overview. Curr. Protein Pept. Sci. 19, 221–233 (2018).
pubmed: 28925902
Yamaguchi, T. Crucial role of CGI-58/alpha/beta hydrolase domain-containing protein 5 in lipid metabolism. Biol. Pharm. Bull. 33, 342–345 (2010).
pubmed: 20190389 doi: 10.1248/bpb.33.342
Chanarin, I. et al. Neutral-lipid storage disease: a new disorder of lipid metabolism. BMJ 1, 553–555 (1975).
pubmed: 1139147 pmcid: 1672681 doi: 10.1136/bmj.1.5957.553
Lefevre, C. et al. Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in chanarin-dorfman syndrome. Am. J. Hum. Genet. 69, 1002–1012 (2001).
pubmed: 11590543 pmcid: 1274347 doi: 10.1086/324121
Radner, F. P. et al. Growth retardation, impaired triacylglycerol catabolism, hepatic steatosis, and lethal skin barrier defect in mice lacking comparative gene identification-58 (CGI-58). J. Biol. Chem. 285, 7300–7311 (2010).
pubmed: 20023287 doi: 10.1074/jbc.M109.081877
Wang, W. et al. Sustained β1-adrenergic stimulation modulates cardiac contractility by Ca
pubmed: 15375008 doi: 10.1161/01.RES.0000145361.50017.aa
Fischer, T. H. et al. Ca
pubmed: 23877259 doi: 10.1161/CIRCULATIONAHA.113.001746
Backs, J., Song, K., Bezprozvannaya, S., Chang, S. & Olson, E. N. CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J. Clin. Invest. 116, 1853–1864 (2006).
pubmed: 16767219 pmcid: 1474817 doi: 10.1172/JCI27438
Backs, J. et al. Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4. J. Cell Biol. 195, 403–415 (2011).
pubmed: 22042619 pmcid: 3206346 doi: 10.1083/jcb.201105063
Lehmann, L. H. et al. A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway. Nat. Med. 24, 62–72 (2018).
pubmed: 29227474 doi: 10.1038/nm.4452
Kronlage, M. et al. O-GlcNAcylation of histone deacetylase 4 protects the diabetic heart from failure. Circulation 140, 580–594 (2019).
pubmed: 31195810 doi: 10.1161/CIRCULATIONAHA.117.031942
Kim, Y. et al. The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J. Clin. Invest. 118, 124–132 (2008).
pubmed: 18079970 doi: 10.1172/JCI33255
Yang, L. K. & Tao, Y. X. Physiology and pathophysiology of the β3-adrenergic receptor. Prog. Mol. Biol. Transl. Sci. 161, 91–112 (2019).
pubmed: 30711031 doi: 10.1016/bs.pmbts.2018.09.003
Wei, J. et al. Reversal of pathological cardiac hypertrophy via the MEF2-coregulator interface. JCI Insight 2, pii: 91068 (2017).
doi: 10.1172/jci.insight.91068
Pouleur, A. C. et al. Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a β3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease β3-left ventricular hypertrophy (β3-LVH). ESC Heart Fail. 5, 830–841 (2018).
pubmed: 29932311 pmcid: 6165933 doi: 10.1002/ehf2.12306
Wang, Y. et al. Adipocyte liver kinase b1 suppresses beige adipocyte renaissance through class iia histone deacetylase 4. Diabetes 66, 2952–2963 (2017).
pubmed: 28882900 pmcid: 5697944 doi: 10.2337/db17-0296
Sohal, D. S. et al. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ. Res. 89, 20–25 (2001).
pubmed: 11440973 doi: 10.1161/hh1301.092687
deAlmeida, A. C., van Oort, R. J. & Wehrens, X. H. Transverse aortic constriction in mice. J. Vis. Exp. 38, e1729 (2010).
Kreusser, M. M. et al. Cardiac CaM kinase II genes delta and gamma contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy. Circulation 130, 1262–1273 (2014).
pubmed: 25124496 pmcid: 4316667 doi: 10.1161/CIRCULATIONAHA.114.006185
Muller, O. J., Schinkel, S., Kleinschmidt, J. A., Katus, H. A. & Bekeredjian, R. Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats. Gene Ther. 15, 1558–1565 (2008).
pubmed: 18615116 doi: 10.1038/gt.2008.111
Geisler, A. et al. microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors. Gene Ther. 18, 199–209 (2011).
pubmed: 21048795 doi: 10.1038/gt.2010.141
Jungmann, A., Leuchs, B., Katus, H. A., Rommelaere, J. & Muller, O. J. Protocol for efficient generation and characterization of adeno-associated viral (AAV) vectors. Hum. Gene Ther. Methods 28, 235–246 (2017).
pubmed: 29048971 doi: 10.1089/hgtb.2017.192
Lehmann, L. H. et al. Essential role of sympathetic endothelin a receptors for adverse cardiac remodeling. Proc. Natl Acad. Sci. USA 111, 13499–13504 (2014).
pubmed: 25197047 pmcid: 4169911 doi: 10.1073/pnas.1409026111
Adams, J. et al. 13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy. Am. J. Pathol. 167, 285–298 (2005).
pubmed: 15972972 pmcid: 1603446 doi: 10.1016/S0002-9440(10)62973-2
Benkert, P., Biasini, M. & Schwede, T. Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics 27, 343–350 (2011).
pubmed: 21134891 doi: 10.1093/bioinformatics/btq662
Bienert, S. et al. The SWISS-MODEL repository-new features and functionality. Nucleic Acids Res. 45, D313–D319 (2017).
pubmed: 27899672 doi: 10.1093/nar/gkw1132
Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296–W303 (2018).
pubmed: 29788355 pmcid: 6030848 doi: 10.1093/nar/gky427
Guex, N., Peitsch, M. C. & Schwede, T. Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective. Electrophoresis 30 (Suppl. 1), S162–S173 (2009).
pubmed: 19517507 doi: 10.1002/elps.200900140
Boeszoermenyi, A. et al. Structure of a CGI-58 motif provides the molecular basis of lipid droplet anchoring. J. Biol. Chem. 290, 26361–26372 (2015).
pubmed: 26350461 pmcid: 4646293 doi: 10.1074/jbc.M115.682203
Badin, P. M. et al. Regulation of skeletal muscle lipolysis and oxidative metabolism by the co-lipase CGI-58. J. Lipid Res. 53, 839–848 (2012).
pubmed: 22383684 pmcid: 3329383 doi: 10.1194/jlr.M019182
Poschl, J. M. et al. Effects of dietary supplementation of saturated fatty acids and of n-6 or n-3 polyunsaturated fatty acids on plasma and red blood cell membrane phospholipids and deformability in weanling guinea pigs. Lipids 34, 467–473 (1999).
pubmed: 10380118 doi: 10.1007/s11745-999-0386-4
Dodt, M., Roehr, J. T., Ahmed, R. & Dieterich, C. FLEXBAR-flexible barcode and adapter processing for next-generation sequencing platforms. Biology (Basel) 1, 895–905 (2012).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886 doi: 10.1093/bioinformatics/bts635
Trapnell, C. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and cufflinks. Nat. Protoc. 7, 562–578 (2012).
pubmed: 22383036 pmcid: 3334321 doi: 10.1038/nprot.2012.016
Alexa, A., Rahnenfuhrer, J. & Lengauer, T. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics 22, 1600–1607 (2006).
pubmed: 16606683 doi: 10.1093/bioinformatics/btl140

Auteurs

Zegeye H Jebessa (ZH)

Institute of Experimental Cardiology, University of Heidelberg, Heidelberg, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany.
Department of Cardiology, University of Heidelberg, Heidelberg, Germany.

Kumar D Shanmukha (KD)

Institute of Experimental Cardiology, University of Heidelberg, Heidelberg, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany.

Matthias Dewenter (M)

Institute of Experimental Cardiology, University of Heidelberg, Heidelberg, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany.

Lorenz H Lehmann (LH)

Institute of Experimental Cardiology, University of Heidelberg, Heidelberg, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany.
Department of Cardiology, University of Heidelberg, Heidelberg, Germany.

Chang Xu (C)

Institute of Experimental Cardiology, University of Heidelberg, Heidelberg, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany.

Friederike Schreiter (F)

Institute of Experimental Cardiology, University of Heidelberg, Heidelberg, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany.

Dominik Siede (D)

Institute of Experimental Cardiology, University of Heidelberg, Heidelberg, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany.

Xue-Min Gong (XM)

Institute of Experimental Cardiology, University of Heidelberg, Heidelberg, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany.

Barbara C Worst (BC)

Institute of Experimental Cardiology, University of Heidelberg, Heidelberg, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany.
Pediatric Glioma Research Group, Hopp Children's Cancer Center Heidelberg (KiTZ) and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Giuseppina Federico (G)

Department of Cellular and Molecular Pathology, German Cancer Research Center, Heidelberg, Germany.

Sven W Sauer (SW)

Department of General Pediatrics, Division of Inborn Metabolic Diseases, University Children's Hospital, Heidelberg, Germany.

Tamas Fischer (T)

John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.

Lisa Wechselberger (L)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.
BioTechMed-Graz, Graz, Austria.

Oliver J Müller (OJ)

Department of Internal Medicine III, University of Kiel, Kiel, Germany.

Samuel Sossalla (S)

Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.

Christoph Dieterich (C)

DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany.
Department of Cardiology, University of Heidelberg, Heidelberg, Germany.

Patrick Most (P)

DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany.
Department of Cardiology, University of Heidelberg, Heidelberg, Germany.

Herrmann-Josef Gröne (HJ)

Department of Cellular and Molecular Pathology, German Cancer Research Center, Heidelberg, Germany.
Institute for Pathology and Nephropathology, University Hospital Marburg, Marburg, Germany.

Cedric Moro (C)

INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.

Monika Oberer (M)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.
BioTechMed-Graz, Graz, Austria.

Guenter Haemmerle (G)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.
BioTechMed-Graz, Graz, Austria.

Hugo A Katus (HA)

DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany.
Department of Cardiology, University of Heidelberg, Heidelberg, Germany.

Jens Tyedmers (J)

Institute of Experimental Cardiology, University of Heidelberg, Heidelberg, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany.

Johannes Backs (J)

Institute of Experimental Cardiology, University of Heidelberg, Heidelberg, Germany. johannes.backs@med.uni-heidelberg.de.
DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany. johannes.backs@med.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH